Thromboprophylaxis among Australasian colorectal surgeons

Thromboembolism is a common cause of morbidity and mortality in patients with colorectal cancer, but thromboprophylaxis (TP) is underutilized. Current guidelines do not make specific recommendations for colorectal cancer patients and provide minimal guidance for the ambulatory setting, although emerging evidence suggests TP may be warranted during chemoradiotherapy or in the extended post‐operative phase. A survey of Australasian colorectal surgeons was therefore performed to assess current TP practice and attitudes.